GlassScriptPhysician profile
Tamara Barsik
NPI 1356320378
$3,516.22
in general payments reported to CMS, 2019-2025
44 companies · $586 in 2025
The $586 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $224 · 2021: $766 · 2022: $492 · 2023: $289 · 2024: $184 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $449.96 | 2019-2023 | |
| Amgen INC. | $366.85 | 2019-2025 | Evenity, Tavneos, Prolia |
| Novo Nordisk INC | $220.96 | 2019-2025 | Ozempic |
| Acadia Pharmaceuticals INC | $173.05 | 2019-2024 | Nuplazid |
| Glaxosmithkline, LLC. | $172.29 | 2019-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Pfizer INC. | $168.37 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $147.53 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $142.77 | 2019-2022 | |
| Abbvie INC. | $135.59 | 2020-2025 | Linzess, Viberzi |
| Bayer Healthcare Pharmaceuticals INC. | $120.22 | 2021-2025 | |
| Biogen, INC. | $101.59 | 2021-2022 | |
| Eisai INC. | $90.61 | 2024-2025 | |
| Inari Medical, INC. | $90.01 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $80.80 | 2024-2025 | |
| Corcept Therapeutics | $80.05 | 2025 | Korlym |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Barsik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.